Prevention of rejection with BTI-322 after renal transplantation (results at 9 months).

scientific article

Prevention of rejection with BTI-322 after renal transplantation (results at 9 months). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0041-1345(97)00432-6
P698PubMed publication ID9270793

P2093author name stringBesse T
Squifflet JP
Awwad M
White-Scharf M
Hope J
Pirson Y
Mourad M
Malaise J
P2860cites workAn anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitroQ71398147
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)2425-2426
P577publication date1997-08-01
P1433published inTransplantation ProceedingsQ7834825
P1476titlePrevention of rejection with BTI-322 after renal transplantation (results at 9 months).
P478volume29

Reverse relations

cites work (P2860)
Q35157558Clinical trials of transplant tolerance: slow but steady progress
Q34494584Contemporary immunosuppression in renal transplantation
Q37123276High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.
Q90118137Safety and pharmacodynamics of anti-CD2 monoclonal antibody treatment in cynomolgus macaques - an experimental study
Q35779272The clinical application of monoclonal antibody therapies in renal transplantation

Search more.